Abstract

Background:Anterior cingulate cortex (ACC) is a critical brain center for chronic pain processing. Dopamine signaling in the brain has been demonstrated to contribute to descending pain modulation. However, the role of ACC dopamine receptors in chronic neuropathic pain remains unclear.Objective:In this study, we investigated the effect of optogenetic activation of ACC dopamine receptors D1- and D2-expressing neurons on trigeminal neuropathic pain.Methods:Chronic constriction injury of infraorbital nerve (CCI-ION) was carried out to induce trigeminal neuropathic pain in mice. We conducted optogenetic stimulation to specifically activate D1- and D2-expressing neurons in the ACC. Western blotting and immunofluorescence staining were used to examine ACC D1 and D2 expression and localization. The von Frey and real-time place preference tests were performed to measure evoked mechanical pain and nonreflexive emotional pain behaviors, respectively.Results:We observed that dopamine receptors D1 and D2 in the ACC are primarily expressed in excitatory neurons and that the D2 receptor is differentially regulated in the early and late phases of trigeminal neuropathic pain. Optogenetic activation of D1-expressing neurons in the ACC markedly exacerbates CCI-ION-induced trigeminal neuropathic pain in both early and late phases, but optogenetic activation of D2-expressing neurons in the ACC robustly ameliorates such pain in its late phase.Conclusion:Our results suggest that dopamine receptors D1 and D2 in the ACC play different roles in the modulation of trigeminal neuropathic pain.

Highlights

  • Dopamine signaling in the brain is involved in descending pain modulation

  • We observed that dopamine receptors D1 and D2 in the Anterior cingulate cortex (ACC) are primarily expressed in excitatory neurons and that the D2 receptor is differentially regulated in the early and late phases of trigeminal neuropathic pain

  • Our results suggest that dopamine receptors D1 and D2 in the ACC play different roles in the modulation of trigeminal neuropathic pain

Read more

Summary

Introduction

Dopamine signaling in the brain is involved in descending pain modulation. Previous studies have shown that the regulation of dopamine receptors can be used as a therapeutic approach for trigeminal neuralgia [1,2,3,4], which is characterized by chronic neuropathic pain in facial skin innervated by trigeminal nerve [5,6,3,7]. Dopamine receptors in the ACC contribute to a number of neuropsychiatric and neurological disorders, including schizophrenia, depression, and pain [11,12,9,13,14,15,16,17]. We further found that Sp5C D2, but not D1, mediates descending pain inhibition [18] These results suggest that D1 and D2 receptors at the brainstem level (such as Sp5C) are differentially involved in the modulation of trigeminal neuropathic pain, but the role of these dopamine receptors at the cortical level in pain modulation is still unclear. The role of ACC dopamine receptors in chronic neuropathic pain remains unclear

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call